MOESM1 of Specific cancer stem cell-therapy by albumin nanoparticles functionalized with CD44-mediated targeting

Additional file 1. Fig. S1. MALDI-TOFâ MS spectrum of eBSA. Fig. S2. A working curve for quantification of HA content in HA-eNPs using Alcian blue assay. Fig. S3 Difference on expression of CD44 between B16F10 and MCF-7 cells. Fig. S4 In vitro antitumor effects of NP formulations on the MCF-7 cells. Fig. S5. Time-dependent intensity of fluorescence distribution of eNPs in mouse. Fig. S6. HA-eNPs/ATRA reduced the tumorigenicity of CD44-enriched B16F10 cells.